Medaphor announces intention to float on AIM

RNS Number : 8869O

IP Group PLC

12 August 2014

 

FOR RELEASE ON

12 August 2014

IP Group plc - Portfolio company Medaphor announces intention to float on AIM

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property based businesses, is pleased to note that portfolio company Medaphor Group plc ("Medaphor" or "the Company") has announced its intention to raise funds and to apply for the admission of ordinary shares to trading on AIM.

Medaphor is a global provider of advanced ultrasound education and training simulators for medical professionals. Its lead product is the ScanTrainer ultrasound simulator training platform which assists students, doctors and sonographers to acquire ultrasound scanning skills with minimal expert supervision and without the need of a patient to practise on.

IP Group holds an undiluted beneficial stake of 47.5% in Medaphor, a spin-out company from the University of Cardiff, while IP Venture Fund II LP, a venture capital fund managed by the Group, has a 3.7% stake.

Cenkos Securities is acting for Medaphor in relation to the proposed Admission.

Admission to trading on AIM is expected to take place on 27 August 2014.

For more information, please contact:

IP Group plc	www.ipgroupplc.com
Alan Aubrey, Chief Executive Officer	[phone]
Liz Vaughan-Adams, Communications	[phone] / [phone] [e-mail]
FTI Consulting
John Dineen	[phone]

Notes for editors

About IP Group

IP Group is a leading UK intellectual property commercialisation company, developing technology innovations primarily from its research intensive partner universities. The Group offers more than traditional venture capital, providing its companies with access to business building expertise, networks, recruitment and business support.

IP Group's portfolio comprises holdings in around 90 early stage to mature businesses across the Healthcare, Biotech, Cleantech and Technology sectors. These businesses include Oxford Nanopore Technologies, the DNA sequencing development company, Revolymer, best known for its removable chewing gum and Xeros, which has received many accolades for its revolutionary clothes washing techniques with a much reduced requirement for water.

For more information, please visit our website at www.ipgroupplc.com.

Ends

 

END

 

 

NRAGIGDICDBBGSD